Toggle Offcanvas
...
 
Amlodipine Tenders

Amlodipine Tenders

View Amlodipine tenders, RFPs and contracts. Bid on readily available Amlodipine tenders with the best and most comprehensive tendering platform, since 2002.
Amlodipine is a long acting calcium channel blocker used to treat hypertension and angina. It works by relaxing blood vessels, reducing blood pressure, and improving blood flow to the heart. Amlodipine is commonly prescribed due to its effectiveness and relatively mild side effects, which may include dizziness, swelling in the legs, and flushing.

Bidding for Amlodipine tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Amlodipine.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Amlodipine market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Amlodipine tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

142 Live Notices for Amlodipine Tenders

Showing 1 to 20

Zakupa Leagest Minister And Mandytskins Prinadleev, Dulyen, Haidar Belts №3 Nayar Purchase Of Medicines And Medical Supplies For Needs Of Natar Homeltar B.Ga Kaydar Olafurov
country Tajikistan
posting date02 May 2025
deadline23 May 2025
Buy Amlodipine 5Mg Tab
country Jordan
posting date30 Apr 2025
deadline20 May 2025
Acquisition Of Antihypertensive, Antimicotic, Anti -Inflammatory, Corticosteroid, Antidiabetic, Vitamins And Laxative Medications, For Pasteur Hospital. Quote According To Attached File.
country Uruguay
posting date28 Apr 2025
deadline14 May 2025
Purchase Of Drugs And Medical Consumables Haridi Mavodii Doruvorӣ Va Masrafshandai Tibbӣ
country Tajikistan
posting date24 Apr 2025
deadline14 May 2025
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Perindopril And Amlodipine, Atc C09Bb04 For The Period 01.04.2025 - 31.03.2027
country Germany
posting date17 Feb 2025
deadline05 Feb 2027
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Perindopril And Amlodipine, Atc C09Bb04 For The Period 01.04.2025 - 31.03.2027
country Germany
posting date17 Feb 2025
deadline05 Feb 2027
Pharmaceutical Discount Agreements From April 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date03 Feb 2025
deadline01 Feb 2027
Pharmaceutical Discount Agreements From April 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date03 Feb 2025
deadline01 Feb 2027
Prescription Service Drug Insurance Supplement Competition
country Saudi Arabia
posting date30 Jan 2025
deadline03 Nov 2025
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Telmisartan + Amlodipine, (Obg) Atc C09Db04 For The Period 01.03.2025 - 28.02.2027
country Germany
posting date17 Jan 2025
deadline05 Jan 2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Telmisartan + Amlodipine, (Obg) Atc C09Db04 For The Period 01.03.2025 - 28.02.2027
country Germany
posting date16 Jan 2025
deadline05 Jan 2027
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So-Called Open House Procedure.
country Germany
posting date31 Oct 2024
deadline31 Dec 2026
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ramipril + Amlodipine + Hct
country Germany
posting date24 May 2024
deadline10 Nov 2025
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ramipril + Amlodipine + Hct
country Germany
posting date23 May 2024
deadline10 Nov 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Amlodipine + Bisoprolol, Atc C07Fb07 For The Period February 1St, 2024 - January 31St, 2026
country Germany
posting date18 Dec 2023
deadline05 Dec 2025
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Amlodipine + Hct + Ramipril, Atc C09Bx03 For The Period February 1St, 2024 - January 31St, 2026
country Germany
posting date18 Dec 2023
deadline05 Dec 2025
Amlosartan Valun Tab. 5/80Mg No28
country Uzbekistan
posting date10 May 2025
deadline10 May 2026
Ko-Amlessa 8 / 2.5 / 10 Mg
country Uzbekistan
posting date10 May 2025
deadline10 May 2026
Kortel N 40 Mg
country Uzbekistan
posting date10 May 2025
deadline10 May 2026
Ehselent Op
country Uzbekistan
posting date07 May 2025
deadline06 May 2026

Share Share this page